|
|
|
|
|
by akiselev
2030 days ago
|
|
> This could be the fastes approval in the whole drugs' history considering that Without a doubt. The closest competitors would be imatinib (3 years) and several other chemotherapy drugs (~5 years) meant to treat malignant tumors. The vast majority of the drugs approved this quickly, with the exception of the HepC treatment, treated diseases with a life expectancy of less than the time it took to approve the drugs so long term side effects was less of a concern. |
|